Next-Gen Minimal Residual Disease Testing : Market Forecast, Transformation, and Long-Term Trajectories
Discover trends, market shifts, and competitive outlooks for the minimal residual disease testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the Minimal Residual Disease Testing Market From 2025 To 2029?
In recent times, the market size for minimal residual disease testing has seen significant growth. The market, which was worth $1.59 billion in 2024, is projected to expand to $1.81 billion in 2025, equating to a compound annual growth rate (CAGR) of 13.9%. The impressive growth during this historic period can be largely credited to progress in cancer research, the demand for treatment monitoring, clinical evidence, regulatory support, and patient outcome improvement.
The market size for minimal residual disease testing is projected to experience substantial expansion in the forthcoming years, escalating to $2.96 billion in 2029 with a compound annual growth rate (CAGR) of 13.1%. Factors contributing to this growth during the forecast period comprise the rise in cancer cases, advancements in therapy, trends in precision medicine, a shift in focus to early detection, and the integration of healthcare systems. The forecast period is also likely to see significant trends such as the incorporation of liquid biopsy methods, emphasis on early relapse detection, broadening of MRD testing in clinical trial settings, enhanced use in pediatric oncology, and partnerships established for research and development.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9970&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Minimal Residual Disease Testing Market?
The rise in cancer cases is anticipated to drive the expansion of the minimal residual disease testing market. Cancer occurs when certain body cells multiply uncontrollably and invade other parts of the body. Minimal residual disease testing, a highly sensitive technique for locating cancer cells in the body, is primarily used to determine the stages of cancer. This aids cancer patients in early intervention, thereby stimulating the minimal residual disease testing market. For instance, reports from the American Cancer Society Inc., a nonprofit organization based in the US, suggest that nearly 1.9 million new cancer cases are expected to be reported in 2022, leading to an approximate 609,360 cancer-related deaths in the US within the same year. Hence, the escalating prevalence of cancer is a key factor propelling the growth of the minimal residual disease testing market.
Which Key Market Segments Comprise the Minimal Residual Disease Testing Market and Drive Its Revenue Growth?
The minimal residual disease testing market covered in this report is segmented –
1) By Test Type: DNA – Based Test, RNA- Based Test, Immunological Test
2) By Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies
3) By Application: Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Other Application
4) By End User: Hospitals And Specialty Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users
Subsegments:
1) By DNA-Based Test: Polymerase Chain Reaction (PCR) Tests, Next-Generation Sequencing (NGS), Digital PCR
2) By RNA-Based Test: Reverse Transcription PCR (RT-PCR), RNA Sequencing, Quantitative PCR (qPCR)
3) By Immunological Test: Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=9970&type=smp
Which Areas Are Leading Regions in the Minimal Residual Disease Testing Market Expansion Across the Globe?
North America was the largest region in the minimal residual disease testing market in 2024. The regions covered in the minimal residual disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Key Market Trends in the Minimal Residual Disease Testing Market Over the Coming Years?
The influx of product innovations is a rising trend within the minimal residual disease testing market. Leading companies within this market are introducing innovative new products in order to retain and strengthen their position. To illustrate, the Twist MRD Panel was launched by the US-based synthetic biology and genomics company, Twist Bioscience, in 2022. This new tool is intended to boost research and development within the minimal residual disease (MRD) cancer screening sector. The Twist MRD Panel’s custom configurability can identify minuscule levels of remaining cancer cells in a patient’s bloodstream. It has been designed to seamlessly blend into a conventional next-generation sequencing (NGS) workflow and deliver minimal residual disease (MRD) results within five days.
View the full report here:
How Is the Minimal Residual Disease Testing Market Conceptually Defined?
Minimal residual disease testing refers to a very sensitive test to detect cancer cells in the patient’s body that may remain after treatment. It is used to monitor the effectiveness of cancer treatment and inform future treatment strategies.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9970
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
